NCT04805073View on ClinicalTrials.gov

Treatment of Pruritus With Intramuscular Promethazine

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
PruritusPregnancy Related
Interventions
DRUG

Promethazine

1cc 25mg/ml Promethazine (study medication)

DRUG

Placebo

1cc 0.9% Sodium Chloride (placebo)

Trial Locations (1)

32610

UF Health at the University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT04805073 - Treatment of Pruritus With Intramuscular Promethazine | Biotech Hunter | Biotech Hunter